| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 71335-2549-1 | 71335-2549 | HUMAN PRESCRIPTION DRUG | Levothyroxine Sodium | Levothyroxine Sodium | TABLET | ORAL | 20250121 | N/A | ANDA | ANDA209713 | Bryant Ranch Prepack | LEVOTHYROXINE SODIUM | .025 mg/1 | 30 TABLET in 1 BOTTLE (71335-2549-1) |
| 68788-8793-3 | 68788-8793 | HUMAN PRESCRIPTION DRUG | Levothyroxine Sodium | Levothyroxine Sodium | TABLET | ORAL | 20241217 | N/A | ANDA | ANDA209713 | Preferred Pharmaceuticals Inc. | LEVOTHYROXINE SODIUM | .175 mg/1 | 30 TABLET in 1 BOTTLE (68788-8793-3) |
| 71335-2549-2 | 71335-2549 | HUMAN PRESCRIPTION DRUG | Levothyroxine Sodium | Levothyroxine Sodium | TABLET | ORAL | 20250121 | N/A | ANDA | ANDA209713 | Bryant Ranch Prepack | LEVOTHYROXINE SODIUM | .025 mg/1 | 90 TABLET in 1 BOTTLE (71335-2549-2) |
| 50090-7767-0 | 50090-7767 | HUMAN PRESCRIPTION DRUG | Levothyroxine Sodium | Levothyroxine Sodium | TABLET | ORAL | 20251117 | N/A | ANDA | ANDA209713 | A-S Medication Solutions | LEVOTHYROXINE SODIUM | .137 mg/1 | 90 TABLET in 1 BOTTLE (50090-7767-0) |